A review of the nonmedical use of ketamine: use, users and consequences (Q34157734)

31 July 2017

1 reference

title

A review of the nonmedical use of ketamine: use, users and consequences (English)

1 reference

31 July 2017

Jansen KL

1

1 reference

PubMed ID

11210204

31 July 2017

language of work or name

1 reference

1 October 2000

1 reference

Journal of Psychoactive Drugs

31 July 2017

1 reference

31 July 2017

32

1 reference

31 July 2017

4

1 reference

31 July 2017

419-433

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

31 July 2017

1 reference

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Histopathology after repeated intrathecal injections of preservative-free ketamine in the rabbit: a light and electron microscopic examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Acute reversible cataract induced by xylazine and by ketamine-xylazine anesthesia in rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

The schizophrenia ketamine challenge study debate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine blocks the plasticity associated with prefrontal cortex self-stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

The nagging question of the function of N-acetylaspartylglutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Illicit use of ketamine in Scotland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Lithium stimulates glutamate "release" and inositol 1,4,5-trisphosphate accumulation via activation of the N-methyl-D-aspartate receptor in monkey and mouse cerebral cortex slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Synergistic inhibition of muscarinic signaling by ketamine stereoisomers and the preservative benzethonium chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Observations on delta homeostasis, the one-stimulus model of NREM-REM alternation and the neurobiologic implications of experimental dream studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Dystonic reaction after ketamine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Pharmacokinetics and analgesic effects of i.m. and oral ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

The psychotropic effect of ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

A consideration of ketamine dreams

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine: its mechanism(s) of action and unusual clinical uses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Cocaine and the AP-1 transcription factor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Non-medical use of ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine--can chronic use impair memory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Near death experience and the NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Psychomimetic reactions after low-dose ketamine infusion. Comparison with neuroleptanaesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine psychedelic therapy (KPT): a review of the results of ten years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

The effect of music on ketamine induced emergence phenomena.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Psychological Changes in Children after Anaesthesia: A Comparison between Halothane and Ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine dependence in anesthesia providers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Repeated ketamine administration produces up-regulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Halothane and diazepam inhibit ketamine-induced c-fos expression in the rat cingulate cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

High-dose ketamine does not induce c-Fos protein expression in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine stereoselectively inhibits rat dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Recurrent hallucinations following ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Psychotomimesis mediated by kappa opiate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine increases the amplitude of the 40-Hz auditory steady-state response in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Influence of different anaesthetics on extracellular aminoacids in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Are there long-term effects of ketamine on the central nervous system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Adverse reactions to ketamine anaesthesia. Abolition by a psychological technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Respiratory arrest following intramuscular ketamine injection in a 4-year-old child

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine in the ED: medical politics versus patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Depression of Laryngeal Reflexes during Ketamine Anaesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine abusers presenting to the emergency department: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Ketamine protects cultured neocortical neurons from hypoxic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Pharmacological properties of ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

Arterial Hypoxemia Caused by Intravenous Ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400244

10.1080/02791072.2000.10400244

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11210204